Health Forte Biosciences shares surge after argenx agrees to acquire company for $2.2B By Proactive 27/07
Health Capricor Therapeutics shares tumble after FDA reviewers raise concerns over Duchenne therapy By Proactive 27/07
Health hVIVO CEO sees strong H2 2026 revenue outlook as development platform expands - ICYMI By Proactive 25/07
Mining SMALL-CAP MOVERS: Nasdaq-bound Scancell catches the eye as AIM's headcount falls to 612 By Ian Lyall 24/07
Health AOTI surges as Medicaid decision offers potential to improve growth rates, says analyst By Oliver Haill 24/07
Health AOTI looks to nationwide Medicare coverage to expand addressable market By Jamie Ashcroft 24/07
Health Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi By Oliver Haill 23/07
Health Scancell to join Nasdaq through Neuphoria merger and $89 million funding package By Ian Lyall 23/07
Health Hikma recovery story still has further to run after recent rally, says Panmure By Oliver Haill 22/07
Health Vitura Health appoints senior leaders as streamlined structure targets A$1 million in annual savings By Proactive 22/07
Health Jefferies resumes GSK coverage at 'buy', sees 30% upside on oncology firepower By Ian Lyall 17/07
Health Thalia Therapeutics eyes clinical-stage transition as shareholders vote on Sanmirna deal By Ian Lyall 17/07
Health Citi starts Hikma at 'buy' with strategy reset offering compelling entry point By Ian Lyall 16/07
Health UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results By Proactive 16/07